TABLE 7.
Attributes | Last post prendial glucose measurement (mg/dL) | Self-monitoring testing performed at bed time | Receives GLP-1 analogues | # of sorts of required hospitalization (macro/microvascular, hypo) | Receives amylin agonist | Receives more than 2 OGLD | Patient living in | Follow healthy diet and exercise plan | Covered by a health insurance | Device used for insulin: Vials and syringes | # of different cardiovascular treatments | Received biguanides | Type of health insurance | Treated for other form of dyslipidemia | Cumulated # of individual therapies taken by the patient | Times seen by a diabetologist in the past 3 months | # of OGLD | Last fasting blood glucose measurement (mg/dL) | Last postprandial glucose measurement (mg/dL) | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Algorithm | # of distinct attributes | Subgroups Ranking | No | No | 0 | No | No | Urban area | Yes | Yes | No | No | Public | Yes | 0 | 1 | ||||||
APRIORI-SD | 8 | S1 | X | X | ||||||||||||||||||
S2 | X | X | X | |||||||||||||||||||
S3 | X | X | ||||||||||||||||||||
S4 | X | |||||||||||||||||||||
S5 | X | X | X | |||||||||||||||||||
S6 | X | X | X | |||||||||||||||||||
S7 | X | X | X | |||||||||||||||||||
S8 | X | X | ||||||||||||||||||||
S9 | X | X | X | |||||||||||||||||||
S10 | X | X | X | |||||||||||||||||||
Q-Finder prognostic mode | 12 | S1 | X | |||||||||||||||||||
S2 | X | |||||||||||||||||||||
S3 | X | X | X | |||||||||||||||||||
S4 | X | X | X | |||||||||||||||||||
S5 | X | X | X | |||||||||||||||||||
S6 | X | X | X | |||||||||||||||||||
S7 | X | X | X | |||||||||||||||||||
S8 | X | X | X | |||||||||||||||||||
S9 | X | X | X | |||||||||||||||||||
S10 | X | X | X |